Native American & Tribal Governments

NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

Deadline: November 12, 2027

Opportunity Number: PAR-25-204

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: November 12, 2027

Status: Posted

CFDA Numbers: 93.279

View Grant

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)

Deadline: May 7, 2026

Opportunity Number: PAR-25-164

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.121

View Grant

NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-105

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.121

View Grant

NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)

Deadline: May 7, 2026

Opportunity Number: PAR-25-166

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.121

View Grant

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

Deadline: September 7, 2026

Opportunity Number: PAR-25-065

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242, 93.866

View Grant

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)

Deadline: September 7, 2026

Opportunity Number: PAR-25-064

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.866, 93.242

View Grant

Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)

Deadline: September 7, 2026

Opportunity Number: PAR-25-039

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

View Grant

Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

Deadline: September 7, 2026

Opportunity Number: PAR-25-040

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

View Grant

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Deadline: September 7, 2026

Opportunity Number: PAR-25-095

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.121, 93.866, 93.393, 93.172

View Grant

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Deadline: September 7, 2026

Opportunity Number: PAR-25-096

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.121, 93.866, 93.172, 93.393

View Grant

Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)

Deadline: March 16, 2026

Opportunity Number: PA-25-246

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: March 16, 2026

Status: Posted

CFDA Numbers: 93.866

View Grant

Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)

Deadline: September 7, 2026

Opportunity Number: PAR-25-067

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

View Grant

Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)

Deadline: September 7, 2026

Opportunity Number: PAR-25-066

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: September 7, 2026

Status: Posted

CFDA Numbers: 93.242

View Grant

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

Deadline: May 7, 2026

Opportunity Number: PAR-25-110

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.855, 93.279, 93.313, 93.242, 93.865

View Grant

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

Deadline: May 7, 2026

Opportunity Number: PAR-25-111

Agency: National Institutes of Health

Open Date: November 18, 2024

Close Date: May 7, 2026

Status: Posted

CFDA Numbers: 93.865, 93.855, 93.279, 93.313

View Grant

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Deadline: February 8, 2027

Opportunity Number: RFA-MH-26-170

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: February 8, 2027

Status: Posted

CFDA Numbers: 93.273, 93.213, 93.866, 93.867, 93.242, 93.286, 93.853, 93.865, 93.173, 93.279

View Grant

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

Deadline: November 5, 2026

Opportunity Number: PAR-25-255

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: November 5, 2026

Status: Posted

CFDA Numbers: 93.399, 93.242, 93.172

View Grant

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2027

Opportunity Number: PAR-25-256

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: January 7, 2027

Status: Posted

CFDA Numbers: 93.399, 93.172

View Grant

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-273

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.351

View Grant

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Deadline: May 4, 2028

Opportunity Number: PA-25-168

Agency: National Institutes of Health

Open Date: November 15, 2024

Close Date: May 4, 2028

Status: Posted

CFDA Numbers: 93.273, 93.865, 93.279, 93.172, 93.313, 93.351, 93.867, 93.310, 93.846, 93.838, 93.847, 93.113, 93.853, 93.397, 93.855, 93.213, 93.361, 93.286, 93.233, 93.242, 93.840, 93.399, 93.398, 93.837, 93.173, 93.121, 93.839, 93.866, 93.396, 93.859

View Grant

Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)

Deadline: March 5, 2026

Opportunity Number: PAR-25-209

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: March 5, 2026

Status: Posted

CFDA Numbers: 93.866

View Grant

Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)

Deadline: April 20, 2027

Opportunity Number: RFA-ES-25-002

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: April 20, 2027

Status: Posted

CFDA Numbers: 93.113

View Grant

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-203

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.859

View Grant

Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)

Deadline: January 7, 2028

Opportunity Number: PAR-25-202

Agency: National Institutes of Health

Open Date: November 14, 2024

Close Date: January 7, 2028

Status: Posted

CFDA Numbers: 93.859

View Grant

Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)

Deadline: June 22, 2026

Opportunity Number: PAR-25-170

Agency: National Institutes of Health

Open Date: November 13, 2024

Close Date: June 22, 2026

Status: Posted

CFDA Numbers: 93.399, 93.853, 93.866

View Grant

Find Grants for Native American & Tribal Governments

NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)

NIDCR Small Grant Program for New Investigators (R03 Clinical Trial Not Allowed)

NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)

Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)

Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)

Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)

Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)

Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)

Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)

Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)

BRAIN Initiative: Development and Validation of Novel Tools to Probe Cell-Specific and Circuit-Specific Processes in the Brain (R01 Clinical Trial Not Allowed)

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R21 Clinical Trial Not Allowed)

Development of Animal Models and Related Biological Materials for Research (R21 Clinical Trial Not Allowed)

Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)

Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)

Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)

Focused Technology Research and Development (R01 Clinical Trial Not Allowed)

Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)

Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)

Advanced Filters